Tuberculosis (TB) is an infectious disease. There is an
increasing burden of Drug Resistant TB (DR-TB)
which is not only difficult to treat and associated with
adverse events during its treatment. Cycloserine is a
broad spectrum antibiotic used as a second-line agent
for DR-TB therapy. Psychiatric adverse drug reactions
are well known. Neurotoxicity with the use of
supplemental pyridoxine is rarely reported. We report
a case of young boy who developed tilting of body to
one side during therapy for DR-TB which included
cycloserine. Magnetic Resonance Imaging (MRI) of
the brain showed reversible bilateral symmetrical
(T2/FLAIR) hyperintensity in dentate nuclei. Clinical
and MRI findings were consistent with cycloserine
toxicity. Symptoms resolved on withdrawing the drug.
MRI findings showed marked reversibility